Healthequity Inc (HQY) Stock: A Closer Look at the Market Potential

The price-to-earnings ratio for Healthequity Inc (NASDAQ: HQY) is above average at 95.17x, Company’s 36-month beta value is 0.49.Analysts have differing opinions on the stock, with 9 analysts rating it as a “buy,” 4 as “overweight,” 1 as “hold,” and 0 as “sell.”

The public float for HQY is 84.20M, and currently, short sellers hold a 6.91% ratio of that floaft. The average trading volume of HQY on June 04, 2025 was 1.16M shares.

HQY) stock’s latest price update

Healthequity Inc (NASDAQ: HQY)’s stock price has plunge by 0.92relation to previous closing price of 102.81. Nevertheless, the company has seen a 2.59% surge in its stock price over the last five trading sessions. zacks.com reported 2025-06-03 that The headline numbers for HealthEquity (HQY) give insight into how the company performed in the quarter ended April 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

HQY’s Market Performance

HQY’s stock has risen by 2.59% in the past week, with a monthly rise of 14.55% and a quarterly rise of 0.75%. The volatility ratio for the week is 1.25% while the volatility levels for the last 30 days are 2.02% for Healthequity Inc The simple moving average for the past 20 days is 5.95% for HQY’s stock, with a 11.73% simple moving average for the past 200 days.

Analysts’ Opinion of HQY

Many brokerage firms have already submitted their reports for HQY stocks, with RBC Capital Mkts repeating the rating for HQY by listing it as a “Outperform.” The predicted price for HQY in the upcoming period, according to RBC Capital Mkts is $112 based on the research report published on May 22, 2025 of the current year 2025.

Raymond James, on the other hand, stated in their research note that they expect to see HQY reach a price target of $115, previously predicting the price at $120. The rating they have provided for HQY stocks is “Strong Buy” according to the report published on March 25th, 2025.

Mizuho gave a rating of “Outperform” to HQY, setting the target price at $126 in the report published on December 04th of the previous year.

HQY Trading at 14.94% from the 50-Day Moving Average

After a stumble in the market that brought HQY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -10.23% of loss for the given period.

Insider Trading

Reports are indicating that there were more than several insider trading activities at HQY starting from SELANDER ROBERT W, who sale 5,750 shares at the price of $77.65 back on Apr 09 ’25. After this action, SELANDER ROBERT W now owns 84,969 shares of Healthequity Inc, valued at $446,513 using the latest closing price.

Stephen Neeleman, the Officer of Healthequity Inc, proposed sale 9,019 shares at $79.88 during a trade that took place back on Apr 08 ’25, which means that Stephen Neeleman is holding shares at $720,433 based on the most recent closing price.

Stock Fundamentals for HQY

Current profitability levels for the company are sitting at:

  • 0.14 for the present operating margin
  • 0.6 for the gross margin

The net margin for Healthequity Inc stands at 0.08. The total capital return value is set at 0.05. Equity return is now at value 4.66, with 2.85 for asset returns.

Based on Healthequity Inc (HQY), the company’s capital structure generated 0.34 points at debt to capital in total, while cash flow to debt ratio is standing at 0.31. The debt to equity ratio resting at 0.52. The interest coverage ratio of the stock is 2.74.

Currently, EBITDA for the company is 337.54 million with net debt to EBITDA at 2.4. When we switch over and look at the enterprise to sales, we see a ratio of 8.17. The receivables turnover for the company is 10.17for trailing twelve months and the total asset turnover is 0.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.06.

Conclusion

In a nutshell, Healthequity Inc (HQY) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Most Popular

Related Posts

favicon-nh
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.